Docket Room.
HB 4469·IL·house

DHS-AFFORDABLE GENERIC DRUGS

In CommitteeFiled Jan 16, 2026
Sponsor: Hoan Huynh
Latest Action

Rule 19(a) / Re-referred to Rules Committee

Mar 27, 2026

Email me when HB 4469 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HB 4469. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill directs the Department of Human Services to form partnerships with FDA‑registered generic drug makers to produce a list of the 100 most‑used generic medicines and sell them at cost‑based, rebate‑free prices. It aims to lower prescription costs for public and private buyers, increase competition, and improve patient access, with reporting requirements and a phased effective date.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HB 4469

3 free questions a day, no account

History

  1. Rule 19(a) / Re-referred to Rules Committee
  2. Assigned to Human Services Committee
  3. Referred to Rules Committee
  4. First Reading
  5. Filed with the Clerk by Rep. Hoan Huynh

Sponsors

  • Hoan Huynh · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HB 4469 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HB 4469 free

Or ask your AI assistant about HB 4469 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice